연구성과로 돌아가기

2020 연구성과별 연구자 정보 (1680 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Cho, Eun Kyung Cho, EK 13 Gachon Univ, Dept Internal Med, Div Oncol, Gil Med Ctr, Incheon, South Korea kihlee@chungbuk.ac.kr;
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Jang, Tae Won Jang, TW 14 Kosin Univ, Dept Internal Med, Gospel Hosp, Busan, South Korea kihlee@chungbuk.ac.kr;
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Kim, Bong-Seog Kim, BS 15 Vet Hlth Serv Med Ctr, Dept Internal Med, Seoul, South Korea AAK-5424-2020 Kim, Jin-Seok kihlee@chungbuk.ac.kr;
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Kim, Joo-Hang Kim, JH 16 CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea kihlee@chungbuk.ac.kr;
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Lee, Sung Sook Lee, SS 17 Inje Univ, Haeundae Paik Hosp, Dept Hematol Oncol, Busan, South Korea kihlee@chungbuk.ac.kr;
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Na, Im-Il Na, II 18 Korea Inst Radiol & Med Sci, Div Hematol Oncol, Dept Internal Med, Korea Canc Ctr Hosp, Seoul, South Korea kihlee@chungbuk.ac.kr;
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Yoo, Seung Soo Yoo, SS 19 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea kihlee@chungbuk.ac.kr;
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea Lee, Ki Hyeong Lee, KH 20 교신저자 Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Div Hematol Oncol,Dept Internal Med, 776 Ilsunhwan Ro, Cheongju 28644, South Korea kihlee@chungbuk.ac.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Cho, Byoung Chul Cho, BC 1 Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Coll Med Seoul, Seoul, South Korea LSL-6088-2024 Cho, ByoungChul 0000-0002-5562-270X Cho, Byoung Chul swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Kim, Dong-Wan Kim, DW 2 Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea AAK-1840-2021 Kim, Yong-Joo swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Park, Keunchil Park, K 3 Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Sch Med, Seoul, South Korea ABD-5852-2021 Park, Keunchil swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Lee, Jong-Seok Lee, JS 4 Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seoungnam, South Korea swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Yoo, Seung Soo Yoo, SS 5 Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Kang, Jin Hyoung Kang, JH 6 Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea KYQ-2256-2024 Kang, Jin Hyoung swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Lee, Sung Yong Lee, SY 7 Korea Univ, Dept Internal Med, Guro Hosp, Seoul, South Korea ADE-2110-2022 Lee, Joo Yong 0000-0002-8693-5792 LEE, SUNG YONG swkim@amc.seoul.kr;
페이지 이동: